Mar 05, 2011
Well!! I just finished reading this article and found it to be most eye-opening!! It makes me wonder who is leading this cosensus panel and why they would possibly believe that routine testing for thryroid conditions should be limited. Especially when the findings of these diseases could considerbly lend earlier treatment for those possibly with diabetes, pregnant women with hypothyrodism, hashimoto's, and many other diseases. These deliberations should be in the betterment of the welfare towards these conditions, not limitations. Not to say anything about the thousands of us that suffer the debilitating symptoms of thyroidism. If Iand my son had be routinely tested at an earlier date we may still have an active thyroid gland. Me and my mother-in-law's pituitary tumors may have been found earlier..My mother-in-law would not have lost her eye sight due to her Pituitary tumor rupture. Young men and women would not be spending thousands upon thousands trying to treat infertility issues. Instead they would be parents.
Subclinical hyperthyroidism is defined as low serum TSH levels associated with normal free T4 and free T3 levels. Why would they want to prevent these routine and early tests? Is it because that it would effect the individual agencies, health maintenance organizations, and the Center for Medicare and Medicaid Services who often use published guidelines to limit reimbursement for both testing and therapy?? As well as the Insurance agencies. Who again are on these panels??
So when our primary-care physicians, physician assistants, and nurse practitioners use guidelines as a care tool, under the assumption that they are the best distillation of advice from research and experts in the field, they could be actually being misled. Our health depends on these findings.
In the statement I copied below of this article, I would hope our praticioners will be allowed to treat their patients instead of having inappropriate guidelines treating us.
"In our view as both practicing and academic endocrinologists, the potential benefits of early detection and treatment of subclinical thyroid dysfunction significantly outweigh the potential side-effects that could result from early diagnosis and therapy. Because the potential harm of early detection and treatment appears to be so minor and preventable, it seems prudent to err on the side of early detection and treatment until there are sufficient data to definitively address these issues."
Thank You for bringing this article to our attention. I have learned some of the significance of the reasons of why our doctors may not be treating their patients but being conservative instead of proactive. With the publication of this article maybe their hands will be untied.